Diversified Healthcare Trust elects David A. Pierce as independent trustee, board expands to seven

DIVERSIFIED HEALTHCARE TRUST

Board increased to seven trustees; David A. Pierce elected as independent trustee effective March 29, 2022.
Pierce is EVP and President, MedSurg at Boston Scientific; also serves on boards of MDMA and MassMedic.
His term expires at the 2023 annual meeting; receives standard independent trustee compensation.
Company entered into standard indemnification agreement with Pierce on same terms as other trustees.
No arrangements or transactions requiring disclosure under Item 404(a) were identified.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

David A. Pierce

Independent Trustee

DHC · DIVERSIFIED HEALTHCARE TRUST

Effective: 2022-03-29
Filed: March 30, 2022, 7:59 PM ET

our Board elected David A. Pierce as an Independent Trustee of our Board with a term to expire at the Company’s 2023 annual meeting to fill the vacancy created by the increase in size of our Board to seven Trustees.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David A. Pierce was elected as Independent Trustee at DIVERSIFIED HEALTHCARE TRUST.

Action: elected
Role: Independent Trustee

Exact text from the filing

our Board elected David A. Pierce as an Independent Trustee of our Board with a term to expire at the Company’s 2023 annual meeting to fill the vacancy created by the increase in size of our Board to seven Trustees.

View on SEC.gov

DIVERSIFIED HEALTHCARE TRUST filing history →

Source: SEC EDGAR

accession 0001104659-22-039564

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.